650 related articles for article (PubMed ID: 28228078)
1. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
2. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
Shaif M; Kushwaha P; Usmani S; Pandey S
J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
[TBL] [Abstract][Full Text] [Related]
3. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
[TBL] [Abstract][Full Text] [Related]
5. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
Thakur K; Sharma G; Singh B; Katare OP
Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
[TBL] [Abstract][Full Text] [Related]
6. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
7. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
8. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
Dadwal A; Mishra N; Narang RK
Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders.
Makhmalzade BS; Chavoshy F
J Adv Pharm Technol Res; 2018; 9(1):2-8. PubMed ID: 29441317
[TBL] [Abstract][Full Text] [Related]
10. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
[TBL] [Abstract][Full Text] [Related]
11. Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers.
Kurmi BD; Tekchandani P; Paliwal R; Paliwal SR
Curr Drug Metab; 2017; 18(5):481-495. PubMed ID: 28228076
[TBL] [Abstract][Full Text] [Related]
12. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP
Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754
[TBL] [Abstract][Full Text] [Related]
13. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches.
Pradhan M; Singh D; Singh MR
J Control Release; 2013 Sep; 170(3):380-95. PubMed ID: 23770117
[TBL] [Abstract][Full Text] [Related]
14. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
[No Abstract] [Full Text] [Related]
15. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
16. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
18. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review.
Bahadur S; Sharma M
Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042
[TBL] [Abstract][Full Text] [Related]
19. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
